Past Events
October 16, 2024 3:30 PM EDT
October 5 - October 9, 2024
September 26, 2024 10:00 AM EDT
September 10, 2024 4:30 PM EDT
August 14, 2024 11:00 AM EDT
June 27, 2024 7:00 AM EDT
June 6, 2024 10:00 AM EDT
New York
January 4, 2024 8:00 AM EST
December 5, 2023 from 5:00 PM to 7:00 PM EST
December 5, 2023 from 5:00 PM to 7:00 PM EST
November 14, 2023 from 1:00 PM to 5:00 PM EST
April 27, 2023 from 5:30 PM to 7:30 PM PDT
November 19, 2022 from 12:00 PM to 12:30 PM EST
Boca Raton, Florida
November 14, 2022 from 7:20 PM to 8:00 PM EST
Las Vegas
October 25, 2022 12:00 PM EDT
January 18, 2022 12:00 PM EST
An atai Life Sciences hosted event featuring a presentation by Key Opinion Leader (KOL) Richard S.E. Keefe, PhD, of Duke University.
Dr. Keefe discussed the current treatment landscape and unmet medical need in treating patients with Cognitive Impairment Associated with Schizophrenia (CIAS), followed by Matthew Pando, PhD, CEO and Co-Founder of Recognify Life Sciences, who discussed the design of the completed Phase 2a trial for RL-007 and the preliminary topline data.
The event took place on January 18, 2022, at 12 PM ET. For those who were unable to listen at the time, a replay of the call is available here and the associated presentation slides can be found below.